Alexander S. Vogel

443 total citations
19 papers, 99 citations indexed

About

Alexander S. Vogel is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Alexander S. Vogel has authored 19 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Hepatology and 5 papers in Oncology. Recurrent topics in Alexander S. Vogel's work include Liver Disease Diagnosis and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Liver Disease and Transplantation (4 papers). Alexander S. Vogel is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Liver Disease and Transplantation (4 papers). Alexander S. Vogel collaborates with scholars based in United States and Germany. Alexander S. Vogel's co-authors include Michael Li, Danny Wong, Stephen D. Zucker, Shilpa Grover, F. Stephen Hodi, Jordan Sack, Osama E. Rahma, Thomas D. Schiano, Ronald Hoffman and John Mascarenhas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Alexander S. Vogel

12 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander S. Vogel United States 5 52 34 33 21 16 19 99
Maria Tampaki Greece 7 27 0.5× 111 3.3× 94 2.8× 8 0.4× 24 1.5× 15 168
Letizia Amadori United States 5 21 0.4× 16 0.5× 18 0.5× 5 0.2× 33 2.1× 13 109
Marie Terroir-Cassou-Mounat France 6 19 0.4× 18 0.5× 12 0.4× 15 0.7× 8 0.5× 9 99
Xuetao Shi China 6 22 0.4× 38 1.1× 17 0.5× 2 0.1× 14 0.9× 18 86
Jiong-Jie Yu China 6 39 0.8× 102 3.0× 57 1.7× 5 0.2× 11 0.7× 13 160
Baek‐Yeol Ryoo South Korea 4 64 1.2× 23 0.7× 24 0.7× 3 0.1× 11 0.7× 9 84
Hatim Karachiwala Canada 6 58 1.1× 79 2.3× 45 1.4× 2 0.1× 18 1.1× 21 147
Mohannad Abu-Hilal United States 4 28 0.5× 5 0.1× 5 0.2× 19 0.9× 12 0.8× 5 59
Yugo Sawai Japan 7 72 1.4× 12 0.4× 42 1.3× 5 0.2× 14 0.9× 10 147
Terri Goldberg United States 6 31 0.6× 59 1.7× 21 0.6× 3 0.1× 25 1.6× 11 98

Countries citing papers authored by Alexander S. Vogel

Since Specialization
Citations

This map shows the geographic impact of Alexander S. Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander S. Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander S. Vogel more than expected).

Fields of papers citing papers by Alexander S. Vogel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander S. Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander S. Vogel. The network helps show where Alexander S. Vogel may publish in the future.

Co-authorship network of co-authors of Alexander S. Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander S. Vogel. A scholar is included among the top collaborators of Alexander S. Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander S. Vogel. Alexander S. Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Michael, Danny Wong, Jordan Sack, et al.. (2024). Outcomes of High-Grade Immune Checkpoint Inhibitor Hepatitis in Hospitalized and Nonhospitalized Patients. Clinical Gastroenterology and Hepatology. 22(7). 1444–1452.e4. 4 indexed citations
2.
Vogel, Alexander S., Dagny Von Ahrens, Brett E. Fortune, et al.. (2024). The Impact of Metabolic Health and Obesity on Liver Transplant Candidates and Recipients. Life. 14(6). 685–685.
3.
Vogel, Alexander S., et al.. (2023). Two DeLIVERies and a transplant: Case report of acute fatty liver of pregnancy requiring liver transplant. Clinical Liver Disease. 22(6). 233–237. 1 indexed citations
4.
Aby, Elizabeth S., Alexander S. Vogel, & Adam C. Winters. (2023). Intersection of Coronavirus Disease 2019 and Alcohol-associated Liver Disease: A Review of Emerging Trends and Implications. Clinical Therapeutics. 45(12). 1164–1170.
5.
Kumar, Navin L., et al.. (2023). Diagnosing the Struggling Fellow. Gastroenterology. 165(5). 1102–1105.e1. 1 indexed citations
6.
Li, Michael, Danny Wong, Jordan Sack, et al.. (2023). Early Liver Specialist Consultation is Associated With Faster Biochemical Resolution of Severe Immune Checkpoint Inhibitor–Induced Hepatitis. Journal of the National Comprehensive Cancer Network. 21(6). 617–626.e3. 7 indexed citations
7.
Aby, Elizabeth S., et al.. (2022). A Framework for Creating a FOAMed Organization in Gastroenterology: Lessons Learned from the Liver Fellow Network. Clinical Gastroenterology and Hepatology. 21(2). 256–259. 1 indexed citations
8.
Li, Michael, Danny Wong, Alexander S. Vogel, et al.. (2021). Effect of corticosteroid dosing on outcomes in high‐grade immune checkpoint inhibitor hepatitis. Hepatology. 75(3). 531–540. 46 indexed citations
9.
Vogel, Alexander S. & Navin L. Kumar. (2021). Learning to Love Endoscopy: Lessons from the Five Love Languages About Creating an Optimal Learning Environment for Endoscopic Trainees. Digestive Diseases and Sciences. 66(10). 3231–3233.
10.
Aby, Elizabeth S., et al.. (2021). Sa053 LIVER FELLOW NETWORK: A SURVEY OF THE IMPACT OF A NOVEL ONLINE MEDICAL EDUCATION TOOL. Gastroenterology. 160(6). S–399. 1 indexed citations
11.
Im, Gene Y., Alexander S. Vogel, Sander Florman, et al.. (2021). Extensive Health Care Utilization and Costs of an Early Liver Transplantation Program for Alcoholic Hepatitis. Liver Transplantation. 28(1). 27–38. 15 indexed citations
12.
Tremblay, Douglas, Juan Putra, Alexander S. Vogel, et al.. (2019). The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with Ruxolitinib. SHILAP Revista de lepidopterología. 2019. 1–3. 8 indexed citations
13.
Tremblay, Douglas, Alexander S. Vogel, Erin Moshier, et al.. (2019). Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience. European Journal Of Haematology. 104(1). 72–73. 13 indexed citations
14.
Trojan, Jörg, Thomas Berg, Peter Buggisch, et al.. (2017). Beste supportive Behandlung bei Patienten mit therapie-refraktärem, hepatozellulären Karzinom (HCC) – Ergebnisse einer Delphi-Studie. Zeitschrift für Gastroenterologie.
15.
16.
Stickel, Felix, Jonas Rosendahl, M.Y. Morgan, et al.. (2017). Genetic variation of PNPLA3 and TM6SF2 associate with hepatocellular carcinoma in patients with alcohol-related cirrhosis. Journal of Hepatology. 66(1). S174–S174. 1 indexed citations
17.
Vogel, Alexander S., Samantha L. Gelfand, Robert Fallar, Peter Gliatto, & Reena Karani. (2014). The Third-Year Preview Program: A Near-Peer Shadowing for Second-Year Students with Third-Year Medical Students. MedEdPORTAL.
18.
Kirstein, Martha M., et al.. (2014). P396 PREDICTION OF SHORT- AND LONG-TERM OUTCOME IN PATIENTS WITH AUTOIMMUNE HEPATITIS. Journal of Hepatology. 60(1). S200–S200.
19.
Schweitzer, Nóra, et al.. (2013). Prognostische Faktoren bei Patienten mit cholangiozellulärem Karzinom - monozentrische Analyse von 570 Patienten. Zeitschrift für Gastroenterologie. 51(8). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Tampaki Breakdown of academic impact, for papers by Letizia Amadori Breakdown of academic impact, for papers by Marie Terroir-Cassou-Mounat Breakdown of academic impact, for papers by Xuetao Shi Breakdown of academic impact, for papers by Jiong-Jie Yu Breakdown of academic impact, for papers by Baek‐Yeol Ryoo Breakdown of academic impact, for papers by Hatim Karachiwala Breakdown of academic impact, for papers by Mohannad Abu-Hilal Breakdown of academic impact, for papers by Yugo Sawai Breakdown of academic impact, for papers by Terri Goldberg
Rankless by CCL
2026